Network pharmacology and bioinformatics approach reveals the hypolipidemic mechanism of Dan Tian Jiang Zhi pill
Authors:
- 27 November 2019
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 29 (2) , 243-254
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for Central Universities of the Central South University (31920190155)
- Research Foundation in Scientific and Technological Activities for the Overseas Chinese Scholars (20180013)
- Changjiang Scholar Program, Ministry of Education (IRT_17R88)
This publication has 34 references indexed in Scilit:
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicinesJournal of Cheminformatics, 2014
- Inhibition of LXRα-Dependent Steatosis and Oxidative Injury by Liquiritigenin, a Licorice Flavonoid, as Mediated with Nrf2 ActivationAntioxidants & Redox Signaling, 2011
- Imbalance of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinase-1 and Loss of Fibronectin Expression in Patients with Congestive Heart FailureCardiology, 2010
- Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardiumBiochemical and Biophysical Research Communications, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- Network pharmacologyNature Biotechnology, 2007
- Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular DiseaseCirculation, 2003
- Classification of Obesity and Assessment of Obesity‐Related Health RisksObesity Research, 2002
- Structure and function of gastro-intestinal lipasesAdvanced Drug Delivery Reviews, 1997